Login

I cannot remember my username

Our New Website Is Here!
As part of our merger with St. Paul Research, we’ve created a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through our analysts’ combined insight, expertise, and perspective. Go to my.stpaulresearch.com to access our new site.

Ray Blanco’s FDA Profit Alert

Ray Blanco's FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market.

It is designed to alert you to breakout moves could ultimately drive huge stock market gains...

Flash Sell: Exit This Trade ASAP

Ray Blanco
By Ray BlancoPosted October 28, 2020

Recent trials of the universal flu vaccine failed spectacularly. Are influenza cases being misdiagnosed? Are measures like social distancing and mask wearing causing flu infections to plunge? Or does this vaccine just not work? Regardless of the cause, it’s time to exit this trade.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Ray Blanco’s FDA Profit Alert

The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.

LoginGet Access

Ray Blanco

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Related Posts

Important: Ebola Stock Trading Action Alert

Paul Mampilly
By Paul MampillyPosted October 2, 2014

We're going to need every single Ebola drug that we have to try and help these patients. And then pray that they work. Remember, we have no FDA approved drugs for ebola now. These are all experimental drugs. By experimental, I mean that they have not been proven to work in human beings. Every company with a drug is going to put their drugs into this kind of testing ASAP…

TOPICS | , , , ,

Flash Buy: Big Potential for This Biotech

Ray Blanco
By Ray BlancoPosted August 25, 2020

Biotech stocks can make big gains when they clear clinical or regulatory hurdles—no matter what the general market’s mood is. More often than not, a trading day’s top gainer is some small biomedical stock that produced surprise results or received favorable treatment from the FDA. Today we’re going to play a small biotech with a big upcoming event.

TOPICS | , ,

Flash Sell! Book 44% Gains ASAP

Ray Blanco
By Ray BlancoPosted January 26, 2021

Our Flash Approval Indicator crunches millions of market data points, allowing us to peer into derivative trades made by people “in the know” ahead of FDA rulings. It registered a strong spike earlier this month, suggesting that insider money was pouring into the name. Today, we book that trade for a quick 50% winner!

TOPICS | ,